TCTN1
gene geneOn this page
Also known as FLJ21127TECT1JBTS13
Summary
TCTN1 (tectonic family member 1, HGNC:26113) is a protein-coding gene on chromosome 12q24.11, encoding Tectonic-1 (Q2MV58). Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes.
This gene encodes a member of a family of secreted and transmembrane proteins. The orthologous gene in mouse functions downstream of smoothened and rab23 to modulate hedgehog signal transduction. This protein is a component of the tectonic-like complex, which forms a barrier between the ciliary axoneme and the basal body. A mutation in this gene was found in a family with Joubert syndrome-13. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 79600 — RefSeq curated summary.
At a glance
- Gene–disease (curated): Joubert syndrome 13 (Strong, GenCC) — +2 more curated relationships
- GWAS associations: 2
- Clinical variants (ClinVar): 505 total — 33 pathogenic, 29 likely-pathogenic
- Phenotypes (HPO): 80
- Dosage sensitivity (ClinGen): haploinsufficiency autosomal recessive, triplosensitivity no evidence
- MANE Select transcript:
NM_001082538
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26113 |
| Approved symbol | TCTN1 |
| Name | tectonic family member 1 |
| Location | 12q24.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ21127, TECT1, JBTS13 |
| Ensembl gene | ENSG00000204852 |
| Ensembl biotype | protein_coding |
| OMIM | 609863 |
| Entrez | 79600 |
Gene structure
Transcript identifiers
Ensembl transcripts: 81 — 44 protein_coding, 23 nonsense_mediated_decay, 13 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000377654, ENST00000397655, ENST00000397656, ENST00000397659, ENST00000460357, ENST00000463313, ENST00000464809, ENST00000471804, ENST00000478122, ENST00000480648, ENST00000481093, ENST00000481720, ENST00000482281, ENST00000485445, ENST00000490514, ENST00000491068, ENST00000495659, ENST00000498072, ENST00000546643, ENST00000547461, ENST00000547868, ENST00000549123, ENST00000550703, ENST00000551555, ENST00000551590, ENST00000552038, ENST00000552318, ENST00000552762, ENST00000614115, ENST00000679401, ENST00000679473, ENST00000679617, ENST00000679713, ENST00000680068, ENST00000680168, ENST00000680203, ENST00000680445, ENST00000680512, ENST00000680548, ENST00000680571, ENST00000681395, ENST00000681437, ENST00000681604, ENST00000681703, ENST00000681740, ENST00000681807, ENST00000681851, ENST00000889000, ENST00000889001, ENST00000889002, ENST00000889003, ENST00000889004, ENST00000889005, ENST00000889006, ENST00000889007, ENST00000889008, ENST00000889009, ENST00000889010, ENST00000889011, ENST00000889012, ENST00000889013, ENST00000889014, ENST00000889015, ENST00000889016, ENST00000889017, ENST00000889018, ENST00000889019, ENST00000889020, ENST00000889021, ENST00000889022, ENST00000934350, ENST00000949050, ENST00000949051, ENST00000949052, ENST00000949053, ENST00000949054, ENST00000949055, ENST00000949056, ENST00000949057, ENST00000949058, ENST00000949059
RefSeq mRNA: 8 — MANE Select: NM_001082538
NM_001082537, NM_001082538, NM_001173975, NM_001173976, NM_001319680, NM_001319681, NM_001319682, NM_024549
CCDS: CCDS41833, CCDS41834, CCDS41835, CCDS91749
Canonical transcript exons
ENST00000397659 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001829401 | 110614129 | 110614402 |
| ENSE00002378299 | 110649043 | 110649430 |
| ENSE00003462778 | 110636481 | 110636501 |
| ENSE00003463221 | 110640383 | 110640517 |
| ENSE00003506109 | 110632472 | 110632559 |
| ENSE00003546987 | 110647749 | 110647893 |
| ENSE00003549201 | 110641542 | 110641627 |
| ENSE00003553288 | 110641024 | 110641149 |
| ENSE00003592438 | 110644967 | 110645129 |
| ENSE00003635688 | 110647196 | 110647336 |
| ENSE00003659257 | 110634670 | 110634779 |
| ENSE00003661350 | 110619836 | 110619956 |
| ENSE00003686984 | 110642249 | 110642389 |
| ENSE00003689626 | 110626362 | 110626492 |
| ENSE00003743415 | 110628767 | 110628918 |
Expression profiles
Bgee: expression breadth ubiquitous, 230 present calls, max score 98.58.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 24.2924 / max 333.3522, expressed in 1775 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 128004 | 22.1586 | 1772 |
| 128003 | 1.0897 | 731 |
| 128005 | 1.0440 | 635 |
Top tissues by expression
268 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 98.58 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.56 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 95.32 | gold quality |
| pituitary gland | UBERON:0000007 | 95.28 | gold quality |
| ventricular zone | UBERON:0003053 | 95.02 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.00 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.94 | gold quality |
| bronchial epithelial cell | CL:0002328 | 94.76 | gold quality |
| right testis | UBERON:0004534 | 94.73 | gold quality |
| thyroid gland | UBERON:0002046 | 94.44 | gold quality |
| left testis | UBERON:0004533 | 94.19 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 93.88 | gold quality |
| right ovary | UBERON:0002118 | 93.58 | gold quality |
| left ovary | UBERON:0002119 | 93.42 | gold quality |
| bronchus | UBERON:0002185 | 93.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 92.40 | gold quality |
| metanephros cortex | UBERON:0010533 | 92.32 | gold quality |
| endocervix | UBERON:0000458 | 91.90 | gold quality |
| testis | UBERON:0000473 | 91.89 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.74 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 91.66 | gold quality |
| body of uterus | UBERON:0009853 | 91.54 | gold quality |
| gall bladder | UBERON:0002110 | 91.52 | gold quality |
| right coronary artery | UBERON:0001625 | 91.42 | gold quality |
| right atrium auricular region | UBERON:0006631 | 91.24 | gold quality |
| right adrenal gland | UBERON:0001233 | 91.22 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 91.10 | gold quality |
| ovary | UBERON:0000992 | 91.06 | gold quality |
| left uterine tube | UBERON:0001303 | 90.88 | gold quality |
| left adrenal gland | UBERON:0001234 | 90.64 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 10.76 |
| E-ANND-3 | yes | 7.38 |
| E-GEOD-86618 | no | 48.86 |
Regulation
Is transcription factor: no
Functional genomics
ClinGen dosage: haploinsufficiency 30 (autosomal recessive), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map
Literature-anchored findings (GeneRIF, showing 9)
- Mutations in Tctn1 is associated with ciliopathies. (PMID:21725307)
- TCTN1 may serve as a novel prognostic factor and a potential therapeutic target for glioblastoma. (PMID:25304031)
- These data suggest TCTN1 is essential for glioma cell viability, and dysregulation of TCTN1 may play a key role in glioma tumorigenesis. (PMID:25737023)
- These findings confirmed the direct association between the TCTN1 gene and prostate cancer growth in vitro. (PMID:26310786)
- Flow cytometry analysis showed that depletion of TCTN1 could cause cell cycle arrest at the G2/M phase. This indicates that TCTN1 may be crucial for CRC cell growth. (PMID:28123172)
- we describe the phenotype of a patient with Varadi syndrome who is homozygous for a previously reported mutation in TCTN1 (NM_001082538.2:c.342-2A>G, p.Gly115Lysfs*8) and suggest that allelic disorders linked to TCTN1 include Varadi syndrome, in addition to Joubert syndrome and Meckel-Gruber syndrome. (PMID:28631893)
- Two novel TCTN1 mutations were identified in a family with Joubert syndrome (PMID:31302911)
- microRNA-216a-5p inhibits the development of gastric cancer through target combination with TCTN1. (PMID:32486612)
- Function and transcriptional regulation of TCTN1 in oral squamous cell carcinoma. (PMID:34859261)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tctn1 | ENSDARG00000078447 |
| mus_musculus | Tctn1 | ENSMUSG00000038593 |
| rattus_norvegicus | Tctn1 | ENSRNOG00000028523 |
| caenorhabditis_elegans | WBGENE00017120 |
Paralogs (2): TCTN3 (ENSG00000119977), TCTN2 (ENSG00000168778)
Protein
Protein identifiers
Tectonic-1 — Q2MV58 (reviewed: Q2MV58)
All UniProt accessions (19): A0A087X1J4, A0A0A0MRU7, A0A7P0T8M6, A0A7P0T8R0, A0A7P0T9A6, A0A7P0TA68, A0A7P0TAW1, B4DIB9, E9PIB8, E9PNE4, E9PR69, Q2MV58, F8VQ12, F8VSB8, J3KPW2, S4R2Y1, S4R339, S4R3G2, S4R3M8
UniProt curated annotations — full annotation on UniProt →
Function. Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes. Regulator of Hedgehog (Hh), required for both activation and inhibition of the Hh pathway in the patterning of the neural tube. During neural tube development, it is required for formation of the most ventral cell types and for full Hh pathway activation. Functions in Hh signal transduction to fully activate the pathway in the presence of high Hh levels and to repress the pathway in the absence of Hh signals. Modulates Hh signal transduction downstream of SMO and RAB23.
Subunit / interactions. Part of the tectonic-like complex (also named B9 complex).
Subcellular location. Cytoplasm. Cytoskeleton. Cilium basal body. Secreted.
Disease relevance. Joubert syndrome 13 (JBTS13) [MIM:614173] A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. The disease is caused by variants affecting the gene represented in this entry.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the tectonic family.
Isoforms (6)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2MV58-1 | 1 | yes |
| Q2MV58-2 | 2 | |
| Q2MV58-3 | 3 | |
| Q2MV58-4 | 4 | |
| Q2MV58-5 | 5 | |
| Q2MV58-6 | 6 |
RefSeq proteins (8): NP_001076006, NP_001076007, NP_001167446, NP_001167447, NP_001306609, NP_001306610, NP_001306611, NP_078825 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011677 | TCTN1-3_dom | Domain |
| IPR040354 | TCTN1-3 | Family |
| IPR057724 | TCTN1-3_N | Domain |
Pfam: PF07773, PF25752
UniProt features (18 total): splice variant 8, sequence conflict 3, glycosylation site 3, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2MV58-F1 | 78.10 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3): 36, 295, 528
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-5620912 | Anchoring of the basal body to the plasma membrane |
| R-HSA-1852241 | Organelle biogenesis and maintenance |
| R-HSA-5617833 | Cilium Assembly |
MSigDB gene sets: 310 (showing top):
GOBP_SPINAL_CORD_DEVELOPMENT, GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, GOBP_EPITHELIUM_DEVELOPMENT, GOBP_PROTEIN_LOCALIZATION_TO_CILIUM, GOBP_NEUROGENESIS, GOBP_NEURAL_TUBE_DEVELOPMENT, GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM, GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD, GOBP_DORSAL_VENTRAL_PATTERN_FORMATION, GOBP_FOREBRAIN_DEVELOPMENT, GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION, GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT, MODULE_205, GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT
GO Biological Process (10): in utero embryonic development (GO:0001701), neural tube formation (GO:0001841), regulation of smoothened signaling pathway (GO:0008589), somatic motor neuron differentiation (GO:0021523), telencephalon development (GO:0021537), dorsal/ventral neural tube patterning (GO:0021904), central nervous system interneuron axonogenesis (GO:0021956), cilium assembly (GO:0060271), protein localization to ciliary transition zone (GO:1904491), cell projection organization (GO:0030030)
GO Molecular Function (0):
GO Cellular Component (9): obsolete extracellular space (GO:0005615), cytosol (GO:0005829), membrane (GO:0016020), MKS complex (GO:0036038), extracellular region (GO:0005576), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), ciliary transition zone (GO:0035869), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Assembly of the 9+0 primary cilium | 1 |
| Organelle biogenesis and maintenance | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 6 |
| protein localization to cilium | 2 |
| chordate embryonic development | 1 |
| embryonic epithelial tube formation | 1 |
| neural tube development | 1 |
| smoothened signaling pathway | 1 |
| regulation of signal transduction | 1 |
| spinal cord motor neuron differentiation | 1 |
| forebrain development | 1 |
| anatomical structure development | 1 |
| dorsal/ventral pattern formation | 1 |
| neural tube patterning | 1 |
| central nervous system neuron axonogenesis | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| cellular component organization | 1 |
| cytoplasm | 1 |
| protein-containing complex | 1 |
| ciliary transition zone | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
744 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TCTN1 | B9D1 | Q9UPM9 | 991 |
| TCTN1 | MKS1 | Q9NXB0 | 987 |
| TCTN1 | CC2D2A | Q9P2K1 | 981 |
| TCTN1 | TMEM216 | Q9P0N5 | 976 |
| TCTN1 | TCTN2 | Q96GX1 | 975 |
| TCTN1 | TMEM67 | Q5HYA8 | 968 |
| TCTN1 | TMEM231 | Q9H6L2 | 964 |
| TCTN1 | TCTN3 | Q6NUS6 | 960 |
| TCTN1 | B9D2 | Q9BPU9 | 953 |
| TCTN1 | CEP290 | O15078 | 946 |
| TCTN1 | AHI1 | Q8N157 | 896 |
| TCTN1 | TMEM237 | Q96Q45 | 862 |
| TCTN1 | NPHP1 | O15259 | 830 |
| TCTN1 | TMEM17 | Q86X19 | 823 |
| TCTN1 | RPGRIP1L | Q68CZ1 | 803 |
IntAct
28 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM231 | TCTN1 | psi-mi:“MI:0914”(association) | 0.640 |
| KNG1 | CTSV | psi-mi:“MI:0914”(association) | 0.530 |
| SLC15A4 | PGRMC1 | psi-mi:“MI:0914”(association) | 0.530 |
| CDH23 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| PSCA | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| GPIHBP1 | SAC3D1 | psi-mi:“MI:0914”(association) | 0.350 |
| CST9L | QSOX1 | psi-mi:“MI:0914”(association) | 0.350 |
| NMS | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM25 | NME4 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM231 | TNFRSF10B | psi-mi:“MI:0914”(association) | 0.350 |
| CD160 | PLXNB2 | psi-mi:“MI:0914”(association) | 0.350 |
| IDS | COCH | psi-mi:“MI:0914”(association) | 0.350 |
| DEFB109B | CHST10 | psi-mi:“MI:0914”(association) | 0.350 |
| EDDM3A | PLXNA2 | psi-mi:“MI:0914”(association) | 0.350 |
| LCN9 | C1QL1 | psi-mi:“MI:0914”(association) | 0.350 |
| B9D2 | PARN | psi-mi:“MI:0914”(association) | 0.350 |
| TCTN1 | NPTX1 | psi-mi:“MI:0914”(association) | 0.350 |
| EDN3 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| CST11 | PLXNB2 | psi-mi:“MI:0914”(association) | 0.350 |
| TCTN1 | GUSB | psi-mi:“MI:0914”(association) | 0.350 |
| TCTN1 | TOR1A | psi-mi:“MI:2364”(proximity) | 0.270 |
| TCTN1 | PLOD2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| TCTN3 | TCTN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TCTN2 | TCTN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM231 | TCTN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (173): TCTN1 (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), ASPH (Proximity Label-MS), BCAP31 (Proximity Label-MS), BRI3BP (Proximity Label-MS), CALR (Proximity Label-MS), CALU (Proximity Label-MS), CANX (Proximity Label-MS), CCDC134 (Proximity Label-MS), CKAP4 (Proximity Label-MS), CNPY2 (Proximity Label-MS), CNPY3 (Proximity Label-MS)
ESM2 similar proteins: A2A6C4, A4D0V7, A4FV27, A6QQ85, A7VL23, A8MWV9, B0FP48, D4A6L0, E1BBQ2, E5RIL1, O54715, O73698, O75129, O75631, O76095, P0C8N6, P38574, P40682, Q14C87, Q14DG7, Q15904, Q2MV58, Q3UN70, Q3ZBK7, Q52LC2, Q5PPI4, Q5T848, Q5ZJY9, Q60943, Q61137, Q6PGD0, Q76HP2, Q76HP3, Q80YF6, Q80Z10, Q864V4, Q8BZ64, Q8C419, Q8CB65, Q8CEF9
Diamond homologs: Q2MV58, Q4R9E0, Q6NUS6, Q8BZ64, Q8R2Q6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
505 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 33 |
| Likely pathogenic | 29 |
| Uncertain significance | 183 |
| Likely benign | 196 |
| Benign | 23 |
Top pathogenic / likely-pathogenic (30)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1033279 | NM_001082538.3(TCTN1):c.26_29dup (p.Val11fs) | Pathogenic |
| 1252090 | NM_001082538.3(TCTN1):c.1385dup (p.Trp463fs) | Pathogenic |
| 1374749 | NM_001082538.3(TCTN1):c.156del (p.Arg52fs) | Pathogenic |
| 1374980 | NM_001082538.3(TCTN1):c.1465del (p.His489fs) | Pathogenic |
| 1406500 | NM_001082538.3(TCTN1):c.1527del (p.Ala511fs) | Pathogenic |
| 1410963 | NM_001082538.3(TCTN1):c.736A>T (p.Lys246Ter) | Pathogenic |
| 1454973 | NM_001082538.3(TCTN1):c.1775_1778del (p.Val592fs) | Pathogenic |
| 1455274 | NC_000012.11:g.(?111064147)(111064317_?)del | Pathogenic |
| 1805072 | NM_001082538.3(TCTN1):c.378_381dup (p.Ser128fs) | Pathogenic |
| 183312 | NM_001082538.3(TCTN1):c.342-2A>G | Pathogenic |
| 1903848 | NM_001082538.3(TCTN1):c.822+1G>A | Pathogenic |
| 2000289 | NM_001082538.3(TCTN1):c.210dup (p.Val71fs) | Pathogenic |
| 212386 | NM_001082538.3(TCTN1):c.843+1del | Pathogenic |
| 221983 | NM_001082538.3(TCTN1):c.898C>T (p.Arg300Ter) | Pathogenic |
| 2423665 | NC_000012.11:g.(?111064147)(111074326_?)del | Pathogenic |
| 2921929 | NM_001082538.3(TCTN1):c.256_257del (p.Gln86fs) | Pathogenic |
| 2939936 | NM_001082538.3(TCTN1):c.209_210del (p.Pro70fs) | Pathogenic |
| 2942895 | NM_001082538.3(TCTN1):c.962del (p.Val321fs) | Pathogenic |
| 2948555 | NM_001082538.3(TCTN1):c.1505dup (p.Leu502fs) | Pathogenic |
| 30803 | NM_001082538.3(TCTN1):c.221-2A>G | Pathogenic |
| 3244265 | NC_000012.11:g.(?111057621)(111057781_?)del | Pathogenic |
| 3366343 | NM_001082538.3(TCTN1):c.291C>A (p.Cys97Ter) | Pathogenic |
| 3366636 | NM_001082538.3(TCTN1):c.1114dup (p.Gln372fs) | Pathogenic |
| 3752289 | NM_001082538.3(TCTN1):c.514G>T (p.Glu172Ter) | Pathogenic |
| 4277234 | NM_001082538.3(TCTN1):c.342-2A>C | Pathogenic |
| 4784183 | NM_001082538.3(TCTN1):c.1159_1160dup (p.Leu388fs) | Pathogenic |
| 4793524 | NM_001082538.3(TCTN1):c.256C>T (p.Gln86Ter) | Pathogenic |
| 4848272 | NM_001082538.3(TCTN1):c.1133del (p.Gly378fs) | Pathogenic |
| 829835 | NM_001082538.3(TCTN1):c.1454G>A (p.Trp485Ter) | Pathogenic |
| 833489 | NC_000012.12:g.(?110626342)(110642409_?)del | Pathogenic |
SpliceAI
3540 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:110619834:A:AG | acceptor_gain | 1.0000 |
| 12:110619835:G:GG | acceptor_gain | 1.0000 |
| 12:110619952:GTCAC:G | donor_gain | 1.0000 |
| 12:110619957:G:GG | donor_gain | 1.0000 |
| 12:110626360:A:AG | acceptor_gain | 1.0000 |
| 12:110626360:AG:A | acceptor_gain | 1.0000 |
| 12:110626360:AGG:A | acceptor_gain | 1.0000 |
| 12:110626361:G:GG | acceptor_gain | 1.0000 |
| 12:110626361:GG:G | acceptor_gain | 1.0000 |
| 12:110626361:GGG:G | acceptor_gain | 1.0000 |
| 12:110626361:GGGGC:G | acceptor_gain | 1.0000 |
| 12:110626488:AAACT:A | donor_gain | 1.0000 |
| 12:110626489:AACT:A | donor_gain | 1.0000 |
| 12:110626489:AACTG:A | donor_loss | 1.0000 |
| 12:110626490:ACT:A | donor_gain | 1.0000 |
| 12:110626490:ACTG:A | donor_loss | 1.0000 |
| 12:110626491:CT:C | donor_gain | 1.0000 |
| 12:110626491:CTG:C | donor_loss | 1.0000 |
| 12:110626492:TGT:T | donor_loss | 1.0000 |
| 12:110626493:G:GG | donor_gain | 1.0000 |
| 12:110626493:GT:G | donor_loss | 1.0000 |
| 12:110626494:T:G | donor_loss | 1.0000 |
| 12:110626495:AAG:A | donor_loss | 1.0000 |
| 12:110628796:GAA:G | acceptor_gain | 1.0000 |
| 12:110628916:GAGGT:G | donor_loss | 1.0000 |
| 12:110628917:AGGTG:A | donor_loss | 1.0000 |
| 12:110632470:A:AG | acceptor_gain | 1.0000 |
| 12:110632470:AGTAT:A | acceptor_gain | 1.0000 |
| 12:110632471:G:GG | acceptor_gain | 1.0000 |
| 12:110632471:GTAT:G | acceptor_gain | 1.0000 |
AlphaMissense
3845 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:110632538:T:A | C231S | 0.989 |
| 12:110632539:G:C | C231S | 0.989 |
| 12:110642355:T:C | F433L | 0.988 |
| 12:110642357:T:A | F433L | 0.988 |
| 12:110642357:T:G | F433L | 0.988 |
| 12:110634696:T:A | C247S | 0.986 |
| 12:110634697:G:C | C247S | 0.986 |
| 12:110642379:T:A | C441S | 0.986 |
| 12:110642380:G:C | C441S | 0.986 |
| 12:110647797:T:C | F557L | 0.986 |
| 12:110647799:T:A | F557L | 0.986 |
| 12:110647799:T:G | F557L | 0.986 |
| 12:110634696:T:C | C247R | 0.985 |
| 12:110634672:T:C | F239L | 0.983 |
| 12:110634674:T:A | F239L | 0.983 |
| 12:110634674:T:G | F239L | 0.983 |
| 12:110642356:T:G | F433C | 0.983 |
| 12:110647792:T:A | V555D | 0.983 |
| 12:110632538:T:C | C231R | 0.981 |
| 12:110619904:T:A | C97S | 0.979 |
| 12:110619905:G:C | C97S | 0.979 |
| 12:110626378:T:A | C120S | 0.979 |
| 12:110626379:G:C | C120S | 0.979 |
| 12:110619893:G:A | C93Y | 0.978 |
| 12:110647253:T:A | W513R | 0.978 |
| 12:110647253:T:C | W513R | 0.978 |
| 12:110619847:T:A | C78S | 0.976 |
| 12:110619848:G:C | C78S | 0.976 |
| 12:110619874:T:A | C87S | 0.976 |
| 12:110619875:G:C | C87S | 0.976 |
dbSNP variants (sampled 300 via entrez): RS1000015790 (12:110637145 C>T), RS1000026923 (12:110621966 C>G,T), RS1000055727 (12:110615677 T>A), RS1000128821 (12:110617081 G>A), RS1000163701 (12:110621625 A>G), RS1000323487 (12:110615895 C>T), RS1000332607 (12:110635485 G>T), RS1000536602 (12:110627340 T>A,C), RS1000692619 (12:110633723 C>T), RS1000743230 (12:110649028 TTTTC>T,TTTTCTTTC), RS1000806883 (12:110633336 C>T), RS1000990780 (12:110626639 G>A,T), RS1001138081 (12:110615879 A>C,G), RS1001150475 (12:110637360 T>C), RS1001233529 (12:110641257 A>G)
Disease associations
OMIM: gene MIM:609863 | disease phenotypes: MIM:213300, MIM:249000, MIM:614173
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| Joubert syndrome 13 | Strong | Autosomal recessive |
| Joubert syndrome | Supportive | Autosomal recessive |
| Meckel syndrome | Supportive | Autosomal recessive |
Mondo (4): Joubert syndrome (MONDO:0018772), Meckel syndrome (MONDO:0018921), Joubert syndrome 13 (MONDO:0013608), Joubert syndrome and related disorders (MONDO:0015369)
Orphanet (3): Isolated Joubert syndrome (Orphanet:475), Meckel syndrome (Orphanet:564), Joubert syndrome and related disorders (Orphanet:140874)
HPO phenotypes
80 total (30 of 80 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000003 | Multicystic kidney dysplasia |
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000028 | Cryptorchidism |
| HP:0000037 | Male pseudohermaphroditism |
| HP:0000062 | Ambiguous genitalia |
| HP:0000068 | Urethral atresia |
| HP:0000073 | Ureteral duplication |
| HP:0000175 | Cleft palate |
| HP:0000202 | Orofacial cleft |
| HP:0000221 | Furrowed tongue |
| HP:0000238 | Hydrocephalus |
| HP:0000252 | Microcephaly |
| HP:0000276 | Long face |
| HP:0000293 | Full cheeks |
| HP:0000316 | Hypertelorism |
| HP:0000340 | Sloping forehead |
| HP:0000347 | Micrognathia |
| HP:0000358 | Posteriorly rotated ears |
| HP:0000369 | Low-set ears |
| HP:0000426 | Prominent nasal bridge |
| HP:0000457 | Depressed nasal ridge |
| HP:0000463 | Anteverted nares |
| HP:0000482 | Microcornea |
| HP:0000486 | Strabismus |
| HP:0000508 | Ptosis |
| HP:0000518 | Cataract |
| HP:0000528 | Anophthalmia |
| HP:0000532 | Abnormal chorioretinal morphology |
| HP:0000568 | Microphthalmia |
| HP:0000612 | Iris coloboma |
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002783_383 | Body mass index | 7.000000e-06 |
| GCST002783_540 | Body mass index | 6.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance | 2 |
| Air Pollutants | affects cotreatment, increases abundance, increases expression | 2 |
| Arsenic | decreases expression, increases abundance | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | increases abundance, affects cotreatment, increases expression | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| nickel sulfate | increases expression | 1 |
| methacrylaldehyde | increases abundance, affects cotreatment, increases expression | 1 |
| deguelin | decreases expression | 1 |
| 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide | decreases expression | 1 |
| pyrachlostrobin | decreases expression | 1 |
| picoxystrobin | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acrolein | affects cotreatment, increases expression, increases abundance | 1 |
| Antimycin A | decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Lead | decreases expression | 1 |
| Ozone | affects cotreatment, increases expression, increases abundance | 1 |
| Phenobarbital | affects expression | 1 |
| Rotenone | decreases expression | 1 |
| Selenium | affects cotreatment, decreases expression | 1 |
| Testosterone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
Clinical trials (associated diseases)
3 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT00873678 | Not specified | COMPLETED | Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome |
| NCT01401998 | Not specified | RECRUITING | ARPKD Database Study |
| NCT04874909 | Not specified | COMPLETED | Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) |
Related Atlas pages
- Associated diseases: Joubert syndrome 13, Joubert syndrome, Meckel syndrome, type 1
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Joubert syndrome, Joubert syndrome 13, Joubert syndrome and related disorders, Meckel syndrome